U.S. seeks more information on Novartis lung drug (Reuters)
Monday, October 19th, 2009Reuters – U.S. regulators have asked for more information on dosing proposed for a drug from Novartis AG for “smoker’s lung,” or chronic obstructive pulmonary disease, the Swiss group said on Monday.